rewirebio.iobenchmarks
Configuration

InFusion v0.8 (Tamura et al. 2026)

InFusion v0.8: Default parameters; alignment method Bowtie2; aligner Bowtie2 v2.3.4.3; GRCh38; filtered output used where available.

4 evaluations · 24 results

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for InFusion v0.8 (Tamura et al. 2026). Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluated Checkpoint: v0.8

Evaluations and results

4 evaluations · 24 results. Different protocols are not a single leaderboard.

Sorted by F1 (all fusions, conventional RNA-seq of cell lines) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

Tested configurationProtocol and datasetF1 (all fusions, conventional RNA-seq of cell lines)F1 (all fusions, targeted RNA-seq of cell lines)F1 (driver fusions, conventional RNA-seq of cell lines)F1 (driver fusions, targeted RNA-seq of cell lines)False negatives (all fusions, conventional RNA-seq of cell lines)False negatives (all fusions, targeted RNA-seq of cell lines)False negatives (driver fusions, conventional RNA-seq of cell lines)False negatives (driver fusions, targeted RNA-seq of cell lines)False positives (all fusions, conventional RNA-seq of cell lines)False positives (all fusions, targeted RNA-seq of cell lines)False positives (driver fusions, conventional RNA-seq of cell lines)False positives (driver fusions, targeted RNA-seq of cell lines)Precision (all fusions, conventional RNA-seq of cell lines)Precision (all fusions, targeted RNA-seq of cell lines)Precision (driver fusions, conventional RNA-seq of cell lines)Precision (driver fusions, targeted RNA-seq of cell lines)Recall (all fusions, conventional RNA-seq of cell lines)Recall (all fusions, targeted RNA-seq of cell lines)Recall (driver fusions, conventional RNA-seq of cell lines)Recall (driver fusions, targeted RNA-seq of cell lines)True positives (all fusions, conventional RNA-seq of cell lines)True positives (all fusions, targeted RNA-seq of cell lines)True positives (driver fusions, conventional RNA-seq of cell lines)True positives (driver fusions, targeted RNA-seq of cell lines)
InFusion v0.8 (Tamura et al. 2026)EvaluationAll fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3), CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)0.19Not reportedNot reportedNot reported1,512Not reportedNot reportedNot reported850Not reportedNot reportedNot reported0.24Not reportedNot reportedNot reported0.15Not reportedNot reportedNot reported271Not reportedNot reportedNot reported
InFusion v0.8 (Tamura et al. 2026)EvaluationAll fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3), Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)Not reported0.23Not reportedNot reportedNot reported198Not reportedNot reportedNot reported25Not reportedNot reportedNot reported0.58Not reportedNot reportedNot reported0.15Not reportedNot reportedNot reported34Not reportedNot reported
InFusion v0.8 (Tamura et al. 2026)EvaluationDriver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5), CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)Not reportedNot reported0.6Not reportedNot reportedNot reported35Not reportedNot reportedNot reported0Not reportedNot reportedNot reported1Not reportedNot reportedNot reported0.43Not reportedNot reportedNot reported26Not reported
InFusion v0.8 (Tamura et al. 2026)EvaluationDriver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5), Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)Not reportedNot reportedNot reported0.29Not reportedNot reportedNot reported20Not reportedNot reportedNot reported0Not reportedNot reportedNot reported1Not reportedNot reportedNot reported0.17Not reportedNot reportedNot reported4
All 24 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.19 F1 (all fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'F1' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
1,512 False negatives (all fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'False negative' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
850 False positives (all fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'False positive' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.24 Precision (all fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'Positive predictive value' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.15 Recall (all fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'True positive rate' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, conventional RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
271 True positives (all fusions, conventional RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'True positive' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.23 F1 (all fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'F1' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
198 False negatives (all fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'False negative' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
25 False positives (all fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'False positive' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.58 Precision (all fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'Positive predictive value' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.15 Recall (all fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'True positive rate' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: All fusions, targeted RNA-seq of haematologic cell lines, consensus truth (Tamura et al. 2026 Supplementary Table 3)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
34 True positives (all fusions, targeted RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on all fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-all-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 3, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'True positive' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.6 F1 (driver fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'F1' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
35 False negatives (driver fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'False negative' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0 False positives (driver fusions, conventional RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'False positive' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
1 Precision (driver fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'Positive predictive value' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
0.43 Recall (driver fusions, conventional RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'True positive rate' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, conventional RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: CCLE haematologic malignancy cell lines, conventional RNA-seq (170 cell lines)
26 True positives (driver fusions, conventional RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, conventional RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-conventional

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Conventional RNA-seq of cell lines', row 'InFusion', column 'True positive' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.29 F1 (driver fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'F1' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
20 False negatives (driver fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'False negative' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0 False positives (driver fusions, targeted RNA-seq of cell lines)
count · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'False positive' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
1 Precision (driver fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'Positive predictive value' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
0.17 Recall (driver fusions, targeted RNA-seq of cell lines)
fraction · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'True positive rate' (PDF page text)
Configuration: InFusion v0.8 (Tamura et al. 2026)Protocol: Driver fusions, targeted RNA-seq of haematologic cell lines, validated truth (Tamura et al. 2026 Supplementary Table 5)
Dataset: Haematologic cancer cell lines, hybridisation-capture targeted RNA-seq (26 cell lines)
4 True positives (driver fusions, targeted RNA-seq of cell lines)
count · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

InFusion on driver fusions, targeted RNA-seq (Tamura et al. 2026)

rna-fusion-20261009-protocol-tamura2026-driver-targeted

Aggregation: Not reported

Comparison of gene fusion detection algorithms reveals frequently overlooked driver fusions in hematologic malignancies; Tamura et al. 2026, Supplementary Information (Supplementary Tables 1-12) · Supplementary Table 5, 'Targeted RNA-seq of cell lines', row 'InFusion', column 'True positive' (PDF page text)

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Use this configuration

How it works, versions and access

Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance

No evidence rows match these filters. Choose another scope or clear the search.

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID rna-fusion-20261009-config-tamura2026-infusion.

Source locator: Supplementary Table 1; Methods 'Detection of gene fusions by each algorithm'

Related records

How to cite

InFusion v0.8 (Tamura et al. 2026). Rewire biological model benchmark database, release 2026-11-21-adc15377fab2. https://benchmarks.rewirebio.io/database/configuration/rna-fusion-20261009-config-tamura2026-infusion/

Release 2026-11-21-adc15377fab2. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction